Quorum Innovations LLC
Quorum Innovations is a biopharmaceutical company focused on discovering and developing human microbiome therapeutics. The company aims to become a leader in the emerging field of microbiome therapeutics, leveraging its proprietary drug discovery platform, MiNE™, to identify biotherapeutic candidates that stimulate the innate immune response and restore normal microbiome ecology.
Industries
Nr. of Employees
small (1-50)
Quorum Innovations LLC
Sarasota, Florida, United States, North America
Products
BioEsse (topical microbiome-derived skin product)
Commercial topical skin-health product line formulated with microbiome-derived bioactive extracts for skin applications.
Microbiome-derived therapeutic candidates (lead: atopic dermatitis)
Pipeline of microbiome-derived therapeutic candidates developed for local treatment of chronic inflammatory and barrier-deficiency conditions; lead program targets atopic dermatitis.
Intellectual property portfolio (issued US patents)
Issued US patents covering methods to identify biologically active compounds from microbial biofilm and compositions/methods for improving immune responses and barrier functions.
BioEsse (topical microbiome-derived skin product)
Commercial topical skin-health product line formulated with microbiome-derived bioactive extracts for skin applications.
Microbiome-derived therapeutic candidates (lead: atopic dermatitis)
Pipeline of microbiome-derived therapeutic candidates developed for local treatment of chronic inflammatory and barrier-deficiency conditions; lead program targets atopic dermatitis.
Intellectual property portfolio (issued US patents)
Issued US patents covering methods to identify biologically active compounds from microbial biofilm and compositions/methods for improving immune responses and barrier functions.
Services
Strategic partnerships and joint development
Collaborative preclinical development, joint data generation and license/partnership discussions to advance microbiome-derived candidates toward clinical milestones.
Strategic partnerships and joint development
Collaborative preclinical development, joint data generation and license/partnership discussions to advance microbiome-derived candidates toward clinical milestones.
Expertise Areas
- Microbiome-derived therapeutics
- Anti-biofilm therapeutics
- Translational medicine and early clinical development
- Topical formulation and local delivery
Key Technologies
- Biofilm-based compound discovery
- 96-well biofilm microplate assays
- Anti-adhesion and biofilm detachment assays
- Microbiome-derived bioactive extraction and processing